Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

2,4-diaminobenzenesulphonic acid was noon toxic by oral route in rats

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records
Reference
Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Data is from authorative handbook
Qualifier:
according to guideline
Guideline:
other: refer below principle
Principles of method if other than guideline:
Acute oral toxicity study of 1,3-Phenylenediamine-4-sulfonic acid in rat.
GLP compliance:
not specified
Test type:
other: No data available
Limit test:
yes
Species:
rat
Strain:
not specified
Sex:
not specified
Details on test animals or test system and environmental conditions:
No data available
Route of administration:
oral: unspecified
Vehicle:
not specified
Doses:
3480 mg/kg
No. of animals per sex per dose:
No data available
Control animals:
not specified
Details on study design:
No data available
Statistics:
No data available
Preliminary study:
No data available
Sex:
not specified
Dose descriptor:
LD50
Effect level:
3 480 mg/kg bw
Based on:
test mat.
Remarks on result:
other: 50 % mortality observed
Mortality:
No data available
Clinical signs:
No data available
Body weight:
No data available
Gross pathology:
No data available
Other findings:
No data available
Interpretation of results:
not classified
Remarks:
Migrated informationCriteria used for interpretation of results: EU
Conclusions:
Acute oral LD50 value of 1,3-Phenylenediamine-4-sulfonic acid is considered to be 3480 mg/kg in rat.
Executive summary:

Acute oral toxicity test of 1,3-Phenylenediamine-4-sulfonic acid was conducted with rat in the concentration of 3480 mg/kg mg/kg bw orally. 50 % mortality was observed in treated rat. Therefore, LD50 was considered to be 3480 mg/kg when rats were treated with 2,4-diaminobenzenesulphonic acid orally.

 

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
3 480 mg/kg bw
Quality of whole database:
Data is Klimisch 2 and from Sax’ handbook

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Acute oral toxicity:

Based on the data available for target 2,4-diaminobenzenesulphonic acid (CAS no 88-63-1) and its read across 3-Aminobenzenesulfonic acid (CAS no 121-47-1) and 2- Amino-5-Methylbenzenesulfonic Acid (CAS no 88-44-8) are summarized below

 In a study given by Lewiset al(2012) in Sax’ handbook, acute oral toxicity was mentioned for rat by using 2,4-diaminobenzenesulphonic acid in the concentration of 3480 mg/kg mg/kg bw orally. 50 % mortality was observed in treated rat. Therefore, LD50 was considered to be 3480 mg/kg when rats were treated with 2,4-diaminobenzenesulphonic acid orally.

Based on the prediction done by using Danish (Q) SAR Database (2016), acute oral toxicity was estimated in rats treated with 2,4-diaminobenzenesulphonic acid in the concentration of 5000 mg/kg bw orally. 50 % mortality was observed in treated rats. Therefore, Estimated LD50 was found to be 5000 mg/kg bw when rat were treated with 2, 4-diaminobenzenesulphonic acid orally.   

In a study given by Ministry of Health J-CHECK (2016) for read across, acute oral toxicity was evaluated in Crj:CD (SD) male and female rats by using 3-Aminobenzenesulfonic acid in the concentration of 500, 1000, 2000 mg/kg orally. No effect on survival and body weight were observed in treated rats. Diarrhea with soft feces on the administration day and the following day, and yellow-discolored urine on the administration day were observed at 500 and 1000 mg/kg treated male and female rats. In addition, no gross pathological and histopathological changes were observed in treated male and female rats. Therefore, LD50 was considered to be > 2000 mg/kg bw when Crj:CD (SD) male and female rat were treated with 3-Aminobenzenesulfonic acid orally.  

In the above similar source for anther read across, acute oral toxicity was evaluated in Crj:CD (SD) male and female rats by using2- Amino-5-Methylbenzenesulfonic Acid in the concentration 12000 mg/kg orally. No effect on survival were observed in treated rat at 12000 mg/kg bw Therefore, LD50 was considered to be 12000 mg/kg bw when Crj:CD (SD) male and female rat were treated with 2- Amino-5-Methylbenzenesulfonic Acid orally.  

Thus, based on weight of evidence for for target 2,4-diaminobenzenesulphonic acid (CAS no 88-63-1) and its read across 3-Aminobenzenesulfonic acid (CAS no 121-47-1) and 2- Amino-5-Methylbenzenesulfonic Acid (CAS no 88-44-8) is likely to be non hazardous by oral route in rats.

Justification for selection of acute toxicity – oral endpoint

LD50 was considered to be 3480 mg/kg when rats were treated with 2,4-diaminobenzenesulphonic acid orally.

Justification for classification or non-classification

Based on weight of evidence for for target 2,4-diaminobenzenesulphonic acid (CAS no 88-63-1) and its read across 3-Aminobenzenesulfonic acid (CAS no 121-47-1) and 2- Amino-5-Methylbenzenesulfonic Acid (CAS no 88-44-8) is likely to be non hazardous by oral route in rats.